InvestorsHub Logo
Followers 470
Posts 23605
Boards Moderated 0
Alias Born 02/05/2004

Re: None

Tuesday, 02/28/2017 8:42:48 AM

Tuesday, February 28, 2017 8:42:48 AM

Post# of 130513
SeD BioMedical, Inc. is a "privately held" US start-up

http://www.asx.com.au/asxpdf/20161115/pdf/43cwzt3dpn4vn8.pdf

it's US registered - newly inked in Delaware

no need to "get a foothold in the US market"

they're already here...

SeD BioMedical, Inc. is a shell, has little to no capital reserves, working capital, or tangible assets whatsoever

Let's hear from the Board! I see this as a huge positive. Seems like SeD wants to grow their BioMedical arm and sees AMBS as a good way to get a foothold into U.S. market.



this is sad...Chan Heng Fai can walk away anytime with mimimal exposure to the parent holding company SeD Biomedical International Pte. LLC